USPTO serial 90868155
PRISM
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- CASTRO, GIANCARLO
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PRISM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Scottsdale, AZ
Scottsdale, AZ
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason C. Cameron
Jason C. Cameron JCameron IP Law Firm LLC13102 Plumwood DriveCypress, TX 77429UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, cancer, chronic diseases; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medical use; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of disease specific biomarkers; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test media in the form of reagents, cartridges, chips for measuring detection and sequencing of DNA, RNA, polypeptides; Reagents and media for medical and veterinary diagnostic purposes; Veterinary diagnostic reagents | ABANDONED | — |
| 010 | Diagnostic apparatus for the detection of cancer; Diagnostic apparatus for the detection of periodontal disease; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Blood pressure and diabetic diagnostic medical devices; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Flow cytometers for medical diagnostic uses; Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing detection and sequencing of DNA, RNA, polypeptides; Medical diagnostic apparatus for testing detection and sequencing of DNA, RNA, polypeptides incorporating recorded operating system software; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical instrument for cardiovascular diagnostics; Sample preparation device for medical diagnostic uses | ABANDONED | — |
| 044 | Antibody testing for medical diagnostic or treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; Health assessment services, namely, providing a database in the field of sleep apnea and home sleep testing diagnostic information based on collected data and information all for treatment and diagnostic purposes; Medical diagnostic testing, monitoring and reporting services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of infectious diseases, cancer, chronic diseases; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals; Veterinary testing for diagnostic or treatment purposes; Virus testing for medical diagnostic or treatment purposes; Web-based cardiovascular analysis services for medical diagnostic and treatment purposes; Web-based cardiovascular examination and assessment for medical diagnostic purposes | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2022 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Sep 28, 2022 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Sep 19, 2022 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 19, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 19, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 7, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 7, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 5, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 9, 2021 | NWAP | NEW APPLICATION ENTERED | — |